ArticleToxics2026
CSTAP: An Event-Conditioned Protocol for Toxicological Activation Potential in Coastal Sediments.
Article in Toxics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Coastal sediments can store contaminants for decades and become exposure sources when disturbance alters partitioning, transport, or biological contact. We propose the Coastal Sediment Toxicological Activation Protocol (CSTAP), a theoretical and empirically testable protocol for organizing event-conditioned toxicological activation potential in coastal sediments. The associated Coastal Sediment Toxicological Activation Index (CSTAI) is an exploratory, semi-quantitative score intended for hypothesis generation and future calibration, not a validated toxicity endpoint or regulatory threshold. The CSTAP separates chemical burden, effective bioavailability, mixture pressure, event activation, receptor vulnerability, evidence adequacy, uncertainty priority, and procedural integrity. The primary score alone assigns the exploratory class, whereas evidence adequacy, uncertainty priority, and forensic readiness qualify interpretation without changing the class. The protocol includes benchmark selection, information-source safeguards against double counting, route-resolved receptor weighting, event and mass-conservation checks, data-tier declarations, and validation logic. Limiting-case tests, a reproducible worked example, and illustrative Mediterranean case encodings show internal coherence and reporting structure. The CSTAP is intended to guide monitoring design, scenario comparison, and calibration with paired chemistry, exposure, bioassay, and ecological-effect datasets.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.